A diffusion cell adapted to nuclear imaging instruments for the measurement of molecular release and pharmacokinetics across membranes

Auteurs

Mahmoud Mohamed Omar, Département de génie des mines, de la métallurgie et des matériaux, Centre de recherche sur les matériaux avancés (CERMA), Université Laval, Québec, Canada, Axe Médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Québec, Canada
Myriam Laprise-Pelletier, Département de génie des mines, de la métallurgie et des matériaux, Centre de recherche sur les matériaux avancés (CERMA), Université Laval, Québec, Canada, Axe Médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Québec, Canada
Sophie Lemay, Département de génie des mines, de la métallurgie et des matériaux, Centre de recherche sur les matériaux avancés (CERMA), Université Laval, Québec, Canada, Axe Médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Québec, Canada
Jean Lagueux, Département de génie des mines, de la métallurgie et des matériaux, Centre de recherche sur les matériaux avancés (CERMA), Université Laval, Québec, Canada, Axe Médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Québec, Canada
Ludovic Tuduri, UMR-CNRS 5805 EPOC/LPTC, Université de Bordeaux, Talence, France
Marc-André Fortin, Département de génie des mines, de la métallurgie et des matériaux, Centre de recherche sur les matériaux avancés (CERMA), Université Laval, Québec, Canada, Axe Médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Québec, Canada

Type de document

Études primaires

Année de publication

2021

Langue

Anglais

Titre de la revue

Journal of Controlled Release

Première page

661

Dernière page

675

Résumé

Diffusion cells are routinely used in pharmacology to measure the permeation of pharmaceutical compounds and contaminants across membranes (biological or synthetic). They can also be used to study drug release from excipients. The device is made of a donor (DC) and an acceptor (AC) compartment, separated by a membrane. Usually, permeation of molecules across membranes is measured by sampling from the AC at different time points. However, this process disturbs the equilibrium of the cell. Furthermore, analytical techniques used in association with diffusion cells sometimes lack either accuracy, sensitivity, or both. This work reports on the development of nuclear imaging – compatible diffusion cells. The cell is made of a polymer transparent to high-energy photons typically detected in positron emission tomography (PET). It was tested in a finite-dose set-up experiment with a pre-clinical PET system. Porous cellulose membranes (3.5, 25 and 300 kDa), a common excipient in pharmacology, as well as for dialysis membranes, were used as test membranes. The radioisotope 89Zr chelated with deferoxamine B (DFO; 0.65 kDa), was used as an imaging probe (7–10 MBq; 0.2–0.3 nMol 89Zr-DFO). In medicine, DFO is also commonly used for iron removal treatments and pharmacological formulations often require the association of this molecule with cellulose. Permeation profiles were obtained by measuring the radioactivity in the DC and AC for up to 2 weeks. The kinetic profiles were used to extract lag time, influx, and diffusion coefficients of DFO across porous cellulose membranes. A sensitivity threshold of 0.005 MBq, or 3.4 fmol of 89Zr-DFO, was revealed. The lag time to permeation (τ) measured in the AC compartment, was found to be 1.33, 0.5, and 0.19 h with 3.5, 25, and 300 kDa membranes, respectively. Diffusion coefficients of 3.65 × 10−6, 8.33 × 10−6, and 4.74 × 10−5 cm2 h−1 where revealed, with maximal pseudo steady-state influx values (Jpss) of 6.55 × 10−6, 1.76 × 10−5, and 1.29 × 10−5 nmol cm−2 h−1. This study confirms the potential of the technology for monitoring molecular diffusion and release processes at low concentrations, high sensitivities, in real time and in a visual manner. © 2021 Elsevier B.V.

Mots-clés

Pharmacocinétique, Pharmacokinetics, Équipement et procédé nucléaire, Radiation equipment and process, Pharmacologie, Pharmacology

Numéro de projet IRSST

2015-0084

Ce document n'est pas disponible pour le moment.

Partager

COinS